quinoxalines has been researched along with AIDS Seroconversion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, J; Cui, Q; Elston, D; McFarland, N; McIvor, A; Quan, C; Robinson, L; Smaill, F; Smieja, M; Thabane, L; Zeidler, J | 1 |
| Aweeka, F; Hayashi, S; Jayesekera, D; Jayewardene, A; Shah, A; Thevanayagam, L | 1 |
2 trial(s) available for quinoxalines and AIDS Seroconversion
| Article | Year |
|---|---|
Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.
Topics: Adult; Affect; Benzazepines; Cotinine; Dreams; Female; Follow-Up Studies; HIV Seropositivity; Humans; Indicators and Reagents; Male; Middle Aged; Nausea; Nicotinic Agonists; Ontario; Pilot Projects; Prevalence; Quinoxalines; Sleep Initiation and Maintenance Disorders; Smoking; Smoking Cessation; Treatment Outcome; Varenicline | 2012 |
Altered pharmacokinetics of indinavir by a novel nonnucleoside reverse transcriptase inhibitor (HBY-097): a pharmacokinetic evaluation in HIV-positive patients.
Topics: Adult; Antiviral Agents; Area Under Curve; Drug Interactions; Drug Therapy, Combination; Exanthema; Female; Gastrointestinal Diseases; HIV Protease Inhibitors; HIV Seropositivity; Humans; Indinavir; Male; Middle Aged; Quinoxalines; Reverse Transcriptase Inhibitors; Zidovudine | 1999 |